Dataset Information


Erythropoietin enhances Kupffer cell number and activity in the challenged liver.

ABSTRACT: Erythropoietin (EPO) is the main hormone driving mammalian erythropoiesis, with activity mediated via the surface receptor, EPO-R, on erythroid progenitor cells. Recombinant human EPO is currently used clinically for the treatment of anemia in patients with end-stage renal disease, and in certain cancer patients suffering from anemia induced either by the tumor itself or by chemotherapy. EPO-R expression is also detected in non-erythroid cells, including macrophages present in the peritoneum, spleen, and bone marrow (BM). Here we demonstrate that Kupffer cells (KCs) - the liver-resident macrophages - are EPO targets. We show that, in vitro, EPO initiated intracellular signalling and enhanced phagocytosis in a rat KC line (RKC-2) and in sorted KCs. Moreover, continuous EPO administration in mice, resulted in an increased number of KCs, up-regulation of liver EPO-R expression and ???elevated? production of the monocyte chemoattractant CCL2, with corresponding egress of Ly6Chi monocytes from the BM. In a model of acute acetaminophen-induced liver injury, EPO administration increased the recruitment of Ly6Chi monocytes and neutrophils to the liver. Taken together, our results reveal a new role for EPO in stimulating KC proliferation and phagocytosis, and in recruiting Ly6Chi monocytes in response to liver injury.


PROVIDER: S-EPMC5583293 | BioStudies | 2017-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC5028381 | BioStudies
2020-01-01 | S-EPMC7330839 | BioStudies
1000-01-01 | S-EPMC2176185 | BioStudies
1000-01-01 | S-EPMC4969594 | BioStudies
2018-01-01 | S-EPMC5940200 | BioStudies
2019-01-01 | S-EPMC6783440 | BioStudies
2019-01-01 | S-EPMC6455222 | BioStudies
2016-01-01 | S-EPMC5068243 | BioStudies
1000-01-01 | S-EPMC5660185 | BioStudies
1000-01-01 | S-EPMC6263213 | BioStudies